Conclusion :
Pediatric CML is a serious hematologic malignancy whose differential
diagnosis can be difficult because of the clinical and biological
similarities, particularly with atypical CML. Early diagnosis and
treatment of juvenile chronic myeloid leukemia allows for better
stabilization of the disease, especially with the advent of tyrosine
kinase inhibitors, whose discovery was the key to treating pediatric
CML.